Your Yourlocation: Home > Effect of salmeterol combined with tiotropium bromide(136310-93-5) on chronic obstructive pulmonary disease

Treatment of chronic obstructive pulmonary disease (COPD) with salmeterol / propofolone propionate combined with tiotropium bromide(136310-93-5). 60 patients with COPD who were diagnosed with COPD in 2015 were selected as the control group, 30 patients with conventional COPD symptomatic treatment regimen, and 30 patients treated with salmeterol / propafenone propionate combined with tiotropium observation group. Comparison of two groups of efficacy. The total effective rate was 83.3% in the control group and 96.7% in the observation group. The difference was statistically significant (0.05). The FEV and FEV / FVC in the observation group were significantly higher than those in the control group (0.05). After 6 months of treatment, the distance and quality of life were 6 min. The observation group was superior to the control group, the difference was statistically significant (0.05). Treatment of COPD with salmeterol / propofolone propionate combined with tiotropium bromide(136310-93-5) regimen can improve clinical efficacy and promote physical function recovery.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved